Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir Disoproxil Fumarate in Parkinson's Disease
NCT06356662Phase 1Recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Parkinson's disease (PD) comparing Tenofovir Arm with Placebo Arm (2 arms). Primary endpoint: Unified Parkinson's Disease Rating Scale part 3 at 3 months. Started Jan 2024; status: recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06356662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06356662.